Terumo Recalls Sarns Antegrade Cardioplegia Cannulas Due to Foreign Substance
Terumo CVS is recalling Sarns Antegrade Cardioplegia Cannulas because a foreign substance was found on the inner surface of some tips that could be dislodged.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a dislodgable foreign substance in a medical device used in cardiac surgery, representing a risk of harm where injury has not yet been reported.
Plain-English summary
Terumo Cardiovascular Systems Corporation is recalling Sarns Antegrade Cardioplegia Cannulas. The recall involves 53,139 units distributed worldwide, including the United States and various international locations. The affected product is indicated for placement in the aortic root to deliver cardioplegia solution or blood to the heart during cardiopulmonary bypass procedures.
During production, Terumo CVS identified the presence of a foreign substance on the inner surface of some cannula tips. A preliminary investigation found that this substance can be dislodged from the cannula surface. The substance was likely deposited during the molding process, though the exact composition is not specified in the source text.
The recall includes catalog number 203879 and specific lot numbers: 0558280, 0574328, 0590421, 0607092, 0613016, 0627693, 0641300, 0653436, 0655320, and 0666687. Healthcare providers and facilities should check their inventory for these specific catalog and lot numbers and stop using the affected devices.
The recalled product
- Product
- SARNS ANTEGRADE CARDIOPLEGIA CANNULA: ROOT INFUSION CANNULA WITH 12-GAUGE BLUE NEEDLE,RECTANGULAR FLANGE AND SUTURE COLLAR, 6" (15CM) LONG Product Usage: The Sarns Cardioplegia Cannula and Cardioplegia/Vent Catheters are indicated for placement in the aortic root to deliver c
- Manufacturer
- Terumo Cardiovascular Systems Corporation
- Category
- Medical Device — Cardiac Surgery
- Affected units
- 53,139
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Catalog number: 203879 and lot numbers: 0558280
- 0574328
- 0590421
- 0607092
- 0613016
- 0627693
- 0641300
- 0653436
- 0655320
- and 0666687.
Distribution
Part of a larger recall action
This product is one of 20 recalled by Terumo Cardiovascular Systems Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 20 products in this recall →Related recalls
Same manufacturer · Terumo Cardiovascular Systems Corporation
See all →- HighCDI OneView System BPM Probe temperature sensor measurement inaccuracy
FDA (Devices) · 2025-07-02
- HighTerumo CDI OneView Monitor Probe May Fail to Display Oxygen Saturation Data
FDA (Devices) · 2025-04-09
- HighCardiovascular Procedure Kits Recalled for Pressure Relief Valve Defect
FDA (Devices) · 2024-04-10
- HighCAPIOX FX25 Oxygenator Recalled for Potential Leaks from Improper Bonding
FDA (Devices) · 2023-04-12
- HighTerumo Recalls CAPIOX NX19 Oxygenator Due to Improper Bonding
FDA (Devices) · 2023-04-12
Same hazard · foreign substance
See all →- ModerateHeritage Pharmaceuticals Recalls Clindamycin Palmitate Hydrochloride Due to Foreign Particles
FDA (Drugs) · 2026-08-19
- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- LowHydroxyzine Hydrochloride Oral Solution recalled for foreign substance
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01